The research group of Xinjing Tang developed efficient inhibition of SARS-CoV-2 using chimeric oligonucleotides through RNase L activation Efficient Inhibition of SARS-CoV-2 Using Chimeric oligonucleotides through RNase L Activation

Su, X.; Ma, W.; Feng, D.; Cheng, B.; Wang, Q.; Guo, Z.; Zhou, D.; Tangfis, X.

Su, X.; Ma, W.; Feng, D.; Cheng, B.; Wang, Q.; Guo, Z.; Zhou, D.; Tangfis, X..

Journal of Chinese Pharmaceutical Sciences ; 30(7):621-622, 2021.

Article in English | EMBASE | ID: covidwho-1357962

Search on Google

XML

Collection: Databases of international organizations Database: EMBASE Language: English Journal: Journal of Chinese Pharmaceutical Sciences Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Search on Google

XML

Collection: Databases of international organizations Database: EMBASE Language: English Journal: Journal of Chinese Pharmaceutical Sciences Year: 2021 Document Type: Article